Bibliometric Analysis of Traditional Chinese Medicine in the Treatment of Asthma from 2005 to 2024
Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v5i3.2774
Abstract
Asthma is a complex chronic respiratory disease that affects most people worldwide and imposes a heavy economic and health burden. Traditional Chinese medicine (TCM) is one of the common treatments for asthma; however, there is a lack of bibliometric analysis data on the relationship between bronchial asthma and traditional Chinese medicine. This study analyzes and visualizes current research status and future trends. Relevant English publications on traditional Chinese medicine treatment for bronchial asthma were collected from the Web of Science core collection, and bibliometric analysis was conducted using software like Histcite. A total of 406 articles meeting the criteria were included after manual screening. China (including Taiwan) emerged as the leading contributor, with the Beijing University of Chinese Medicine being the institution with the highest number of publications. 'Journal of Ethnopharmacology' was a significant publication in this domain. The most frequently occurring keyword on the main display platform was 'airway inflammation.' Future research hotspots are expected to focus on intestinal flora and metabolism. This research offers a fresh perspective for understanding developments in this field.
Keywords
asthma, traditional Chinese medicine, acupuncture and moxibustion, literature metrology, CiteSpace
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
SUN J, BAI S, ZHAO J, et al. Mapping knowledge structure and research of the biologic treatment of asthma: A bibliometric study [J]. Front Immunol, 2023, 14: 1034755.
[2] Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 [J]. Lancet Respir Med, 2017, 5(9): 691-706.
[3] HAN J, KANG H J, KIM M, et al. Mapping the intellectual structure of research on surgery with mixed reality: Bibliometric network analysis (2000-2019) [J]. J Biomed Inform, 2020, 109: 103516.
[4] MISHRA V, BANGA J, SILVEYRA P. Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets [J]. Pharmacol Ther, 2018, 181: 169-82.
[5] CHAROKOPOS N, APOSTOLOPOULOS N, KALAPODI M, et al. Bronchial asthma, chronic obstructive pulmonary disease and NF-kappaB [J]. Curr Med Chem, 2009, 16(7): 867-83.
[6] HUFNAGL K, PALI-SCHöLL I, ROTH-WALTER F, et al. Dysbiosis of the gut and lung microbiome has a role in asthma [J]. Semin Immunopathol, 2020, 42(1): 75-93.
[7] BARCIK W, PUGIN B, BRESCó M S, et al. Bacterial secretion of histamine within the gut influences immune responses within the lung [J]. Allergy, 2019, 74(5): 899-909.
[8] ARRIETA M C, STIEMSMA L T, DIMITRIU P A, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma [J]. Sci Transl Med, 2015, 7(307): 307ra152.
[9] DONG Y, YAN H, ZHAO X, et al. Gu-Ben-Fang-Xiao Decoction Ameliorated Murine Asthma in Remission Stage by Modulating Microbiota-Acetate-Tregs Axis [J]. Front Pharmacol, 2020, 11: 549.
[10] HE R, WANG S, YANG S, et al. Shaoyao-Gancao-Tang regulates the T-helper-type 1/T-helper-type 2 ratio in the lung and gut and alters gut microbiota in rats with ovalbumin-induced asthma [J]. J Ethnopharmacol, 2023, 309: 116300.
[11] LI W J, ZHAO Y, GAO Y, et al. Lipid metabolism in asthma: Immune regulation and potential therapeutic target [J]. Cell Immunol, 2021, 364: 104341.
[12] PICADO C, DEULOFEU R, LLEONART R, et al. Lipid and protein metabolism in asthma. Effects of diet and corticosteroid therapy [J]. Allergy, 1999, 54(6): 569-75.
[13] RIED J S, BAURECHT H, STüCKLER F, et al. Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma [J]. Allergy, 2013, 68(5): 629-36.
[14] JIANG T, DAI L, LI P, et al. Lipid metabolism and identification of biomarkers in asthma by lipidomic analysis [J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2021, 1866(2): 158853.
[15] YAN H, QIAN G, YANG R, et al. Huanglong Antitussive Granule Relieves Acute Asthma Through Regulating Pulmonary Lipid Homeostasis [J]. Front Pharmacol, 2021, 12: 656756.
[16] LIU J X, YUAN H Y, LI Y N, et al. Ephedra sinica polysaccharide alleviates airway inflammations of mouse asthma-like induced by PM2.5 and ovalbumin via the regulation of gut microbiota and short chain fatty acid [J]. J Pharm Pharmacol, 2022, 74(12): 1784-96.
[2] Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 [J]. Lancet Respir Med, 2017, 5(9): 691-706.
[3] HAN J, KANG H J, KIM M, et al. Mapping the intellectual structure of research on surgery with mixed reality: Bibliometric network analysis (2000-2019) [J]. J Biomed Inform, 2020, 109: 103516.
[4] MISHRA V, BANGA J, SILVEYRA P. Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets [J]. Pharmacol Ther, 2018, 181: 169-82.
[5] CHAROKOPOS N, APOSTOLOPOULOS N, KALAPODI M, et al. Bronchial asthma, chronic obstructive pulmonary disease and NF-kappaB [J]. Curr Med Chem, 2009, 16(7): 867-83.
[6] HUFNAGL K, PALI-SCHöLL I, ROTH-WALTER F, et al. Dysbiosis of the gut and lung microbiome has a role in asthma [J]. Semin Immunopathol, 2020, 42(1): 75-93.
[7] BARCIK W, PUGIN B, BRESCó M S, et al. Bacterial secretion of histamine within the gut influences immune responses within the lung [J]. Allergy, 2019, 74(5): 899-909.
[8] ARRIETA M C, STIEMSMA L T, DIMITRIU P A, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma [J]. Sci Transl Med, 2015, 7(307): 307ra152.
[9] DONG Y, YAN H, ZHAO X, et al. Gu-Ben-Fang-Xiao Decoction Ameliorated Murine Asthma in Remission Stage by Modulating Microbiota-Acetate-Tregs Axis [J]. Front Pharmacol, 2020, 11: 549.
[10] HE R, WANG S, YANG S, et al. Shaoyao-Gancao-Tang regulates the T-helper-type 1/T-helper-type 2 ratio in the lung and gut and alters gut microbiota in rats with ovalbumin-induced asthma [J]. J Ethnopharmacol, 2023, 309: 116300.
[11] LI W J, ZHAO Y, GAO Y, et al. Lipid metabolism in asthma: Immune regulation and potential therapeutic target [J]. Cell Immunol, 2021, 364: 104341.
[12] PICADO C, DEULOFEU R, LLEONART R, et al. Lipid and protein metabolism in asthma. Effects of diet and corticosteroid therapy [J]. Allergy, 1999, 54(6): 569-75.
[13] RIED J S, BAURECHT H, STüCKLER F, et al. Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma [J]. Allergy, 2013, 68(5): 629-36.
[14] JIANG T, DAI L, LI P, et al. Lipid metabolism and identification of biomarkers in asthma by lipidomic analysis [J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2021, 1866(2): 158853.
[15] YAN H, QIAN G, YANG R, et al. Huanglong Antitussive Granule Relieves Acute Asthma Through Regulating Pulmonary Lipid Homeostasis [J]. Front Pharmacol, 2021, 12: 656756.
[16] LIU J X, YUAN H Y, LI Y N, et al. Ephedra sinica polysaccharide alleviates airway inflammations of mouse asthma-like induced by PM2.5 and ovalbumin via the regulation of gut microbiota and short chain fatty acid [J]. J Pharm Pharmacol, 2022, 74(12): 1784-96.
Copyright © 2024 Jiale Huang, Chengyou Li, Ying Liu, Enping Li, Mingsheng Lei
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License